據報螞蟻集團成立AI創新部NextEvo 谷歌前AI工程師徐鵬擔任負責人
《36氪》引述消息報道,螞蟻集團已在內部成立AI創新研發與應用部門NextEvo,由螞蟻集團副總裁徐鵬擔任負責人。
據了解,NextEvo是螞蟻內部的AI精銳部門,承擔螞蟻AI的所有核心技術研發,包括螞蟻百靈大模型的所有研發工作。去年該部門發表逾30篇AI國際頂刊頂會論文。NextEvo開源的智能大規模分布式深度學習系統DLRover,以及GPU顯存+傳輸優化開源項目GLake彌補國內所在AI垂直領域技術開源的空缺。
此外,徐鵬曾在谷歌工作11年,負責和領導谷歌翻譯的核心技術研發,並參與谷歌顯示廣告系統的算法研發。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.